M. Ilyas Kamboh

Q: What Schools Are Affiliated With M. Ilyas Kamboh

M. Ilyas Kamboh is affiliated with the following schools: Augusta University, University of Pittsburgh

M. Ilyas Kamboh's AcademicInfluence.com Rankings

M. Ilyas Kamboh

Computer Science

#7472

World Rank

#7869

Historical Rank

Computer Engineering

#91

World Rank

#92

Historical Rank

Data Science

#155

World Rank

#158

Historical Rank

Computational Linguistics

#1492

World Rank

#1508

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is M. Ilyas Kamboh Influential?

(Suggest an Edit or Addition)

(See a Problem?)

M. Ilyas Kamboh's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease (2013) (3484)
Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) (1656)
Analysis of shared heritability in common disorders of the brain (2016) (1385)
Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease (2014) (1230)
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. (2008) (926)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
CHRONIC TRAUMATIC ENCEPHALOPATHY IN A NATIONAL FOOTBALL LEAGUE PLAYER: PART II (2005) (573)
APOE and Alzheimer disease: a major gene with semi-dominant inheritance (2011) (528)
Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus (2008) (447)
Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease (2013) (418)
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. (2013) (345)
Emerging Histomorphologic Phenotypes of Chronic Traumatic Encephalopathy in American Athletes (2011) (337)
Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. (2000) (321)
A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism (1995) (316)
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis (2012) (308)
Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related Dementias (2014) (295)
Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk (2008) (280)
Common variants at MS 4 A 4 / MS 4 A 6 E , CD 2 AP , CD 33 and EPHA 1 are associated with late-onset Alzheimer ’ s disease (2011) (274)
DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. (1998) (263)
Ancestral proportions and admixture dynamics in geographically defined African Americans living in South Carolina. (2001) (262)
Population structure in admixed populations: effect of admixture dynamics on the pattern of linkage disequilibrium. (2001) (252)
A NOVEL ALZHEIMER DISEASE LOCUS LOCATED NEAR THE GENE ENCODING TAU PROTEIN (2015) (246)
Expressed hypervariable polymorphism of apolipoprotein (a). (1991) (231)
Caucasian genes in American blacks: new data. (1992) (226)
Genetic polymorphism of paraoxonase and the risk of coronary heart disease. (1997) (220)
Genome-wide association study of Alzheimer's disease (2012) (220)
Chronic traumatic encephalopathy in an Iraqi war veteran with posttraumatic stress disorder who committed suicide. (2011) (209)
Specificity of the STAT4 Genetic Association for Severe Disease Manifestations of Systemic Lupus Erythematosus (2008) (207)
Differential Genetic Associations for Systemic Lupus Erythematosus Based on Anti–dsDNA Autoantibody Production (2011) (205)
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2019) (194)
Molecular Genetics of Late‐Onset Alzheimer's Disease (2004) (188)
Chronic Traumatic Encephalopathy in a National Football League Player. (2006) (181)
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease (2009) (180)
Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations (1986) (172)
Convergent genetic and expression data implicate immunity in Alzheimer's disease (2014) (172)
Genome-Wide Association Study Identifies a Novel Locus Contributing to Type 2 Diabetes Susceptibility in Sikhs of Punjabi Origin From India (2013) (168)
Risk Alleles for Systemic Lupus Erythematosus in a Large Case-Control Collection and Associations with Clinical Subphenotypes (2011) (165)
Meta-analysis of the association between variants in SORL1 and Alzheimer disease. (2011) (159)
Research evaluation and diagnosis of possible Alzheimer’s disease over the last two decades: II (2000) (149)
Transethnic genome-wide scan identifies novel Alzheimer's disease loci (2017) (149)
Analysis of genetic polymorphisms in the transforming growth factor-β1 gene and the risk of Alzheimer's disease (2000) (146)
Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease. (1998) (144)
Late-Onset Alzheimer’s Disease Genes and the Potentially Implicated Pathways (2014) (143)
Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. (2011) (142)
Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. (2014) (140)
Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. (1991) (130)
Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. (2003) (128)
Human transferrin polymorphism. (1987) (125)
HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis (2015) (125)
Research evaluation and diagnosis of probable Alzheimer’s disease over the last two decades: I (2000) (123)
Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: New data and meta‐analysis (2009) (118)
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications (2016) (118)
The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances. (1991) (116)
Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. (2001) (115)
Genome-wide Association Study of Alzheimer’s disease with Psychotic Symptoms (2011) (114)
The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. (1995) (110)
Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. (1993) (108)
The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. (2013) (107)
Genetic studies of human apolipoproteins. V. A novel rapid procedure to screen apolipoprotein E polymorphism. (1988) (106)
Lupus nephritis susceptibility loci in women with systemic lupus erythematosus. (2014) (106)
The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese. (1998) (104)
APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. (1995) (104)
Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease (2000) (96)
Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease (1998) (95)
Apolipoprotein E4 allele presence and functional outcome after severe traumatic brain injury. (2007) (94)
Genome-wide association analysis of age-at-onset in Alzheimer's disease (2012) (93)
In vivo assessment of amyloid‐β deposition in nondemented very elderly subjects (2013) (92)
Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans (2014) (92)
Identification of structural mutations in the fifth domain of apolipoprotein H (beta 2-glycoprotein I) which affect phospholipid binding. (1997) (90)
Genetic Variation in Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 (LOX1) Gene and the Risk of Coronary Artery Disease (2003) (89)
Plasma and cerebrospinal fluid α1‐antichymotrypsin levels in Alzheimer's disease: Correlation with cognitive impairment (2003) (88)
Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene (1998) (87)
Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. (2020) (86)
Association of a Common Interferon Regulatory Factor 5 (IRF5) Variant with Increased Risk of Systemic Lupus Erythematosus (SLE) (2007) (86)
Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting (2018) (85)
Association of CLU and PICALM variants with Alzheimer's disease (2012) (84)
Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites. (1993) (83)
Genetic studies of human apolipoproteins. VI. Common polymorphism of apolipoprotein E in blacks. (1989) (82)
Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease (2002) (79)
Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels (2000) (77)
Genetic studies of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (beta 2-glycoprotein I). (1988) (76)
Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease (2007) (72)
Incidental Cerebral Microbleeds and Cerebral Blood Flow in Elderly Individuals. (2015) (71)
Markers of cholesterol transport are associated with amyloid deposition in the brain (2014) (70)
Expression of differential immune factors in temporal cortex and cerebellum: The role of α‐1‐antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease (1998) (68)
Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans (2017) (67)
TCF7L2 Polymorphisms are Associated with Type 2 Diabetes in Khatri Sikhs from North India: Genetic Variation Affects Lipid Levels (2008) (67)
Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease. (1995) (66)
Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures (2006) (66)
Genetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks. (1989) (66)
Is the urea cycle involved in Alzheimer's disease? (2010) (65)
Genetic association of five apolipoprotein polymorphisms with serum lipoprotein‐lipid levels in African blacks (1999) (65)
Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymorphisms in systemic lupus erythematosus. (2007) (65)
Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of apo A-I and HDL-cholesterol. (1996) (64)
Genetic studies of human apolipoproteins (1989) (64)
'Unique' alleles in admixed populations: a strategy for determining 'hereditary' population differences of disease frequencies. (1991) (63)
The apolipoprotein E ϵ4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease (1997) (63)
Phenotypic effects of apolipoprotein structural variation on lipid profiles: II. Apolipoprotein A‐IV and quantitative lipid measures in the healthy women study (1989) (62)
Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression (2005) (62)
Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the healthy women study. (1990) (57)
Genetic variation in apolipoprotein H (β2-glycoprotein I) affects the occurrence of antiphospholipid antibodies and apolipoprotein H concentrations in systemic lupus erythematosus (1999) (57)
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. (2010) (55)
Association of the 3′ UTR transcription factor LBP‐1c/CP2/LSF polymorphism with late‐onset Alzheimer's disease (2003) (55)
A laboratory manual for human blood analysis (1998) (55)
Shared genetic contribution to ischemic stroke and Alzheimer's disease (2016) (55)
Genetic studies of human apolipoproteins. VII. Population distribution of polymorphisms of apolipoproteins A-I, A-II, A-IV, C-II, E, and H in Nigeria. (1988) (54)
Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus. (2006) (54)
APOE polymorphism and angiographic coronary artery disease severity in the Women's Ischemia Syndrome Evaluation (WISE) study. (2003) (54)
Genetic studies in familial fibrosing alveolitis. Possible linkage with immunoglobulin allotypes (Gm). (1986) (53)
Genetic determinants of disease progression in Alzheimer's disease. (2014) (53)
Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies (2004) (53)
Mitochondrial versus nuclear admixture estimates demonstrate a past history of directional mating. (1997) (52)
Genetic studies of human apolipoproteins. I. Polymorphism of apolipoprotein A-IV. (1987) (52)
Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease (2006) (52)
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups (2018) (52)
Gene-Centric Meta-Analysis of Lipid Traits in African, East Asian and Hispanic Populations (2012) (51)
Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex (2005) (51)
Genetic studies of human apolipoproteins. XVI. APOE polymorphism and cholesterol levels in the Mayans of the Yucatan Peninsula, Mexico (1991) (51)
A hydrophobic sequence at position 313-316 (Leu-Ala-Phe-Trp) in the fifth domain of apolipoprotein H (beta2-glycoprotein I) is crucial for cardiolipin binding. (2000) (51)
Frequent recombination is observed in the distal end of the long arm of chromosome 14. (1989) (50)
Population genetics of apolipoprotein A-4, E, and H polymorphisms in Yanomami Indians of northwestern Brazil: associations with lipids, lipoproteins, and carbohydrate metabolism. (1993) (50)
Evidence supporting a role for the calcium‐sensing receptor in Alzheimer disease (2009) (49)
Association of 3′-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer’s disease (2003) (48)
Genetic variation in the apolipoprotein H (β2-glycoprotein I) gene affects plasma apolipoprotein H concentrations (1999) (47)
Genetic Risk for Schizophrenia and Psychosis in Alzheimer Disease (2017) (47)
Mild Cognitive Impairment that Does Not Progress to Dementia: A Population‐Based Study (2018) (46)
More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk (2015) (45)
Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease (2005) (45)
Age-at-Onset in Late Onset Alzheimer Disease is Modified by Multiple Genetic Loci (2014) (44)
No association between CALHM1 variation and risk of Alzheimer disease (2009) (43)
Molecular basis of the apolipoprotein H (β2-glycoprotein I) protein polymorphism (1997) (43)
Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African‐Americans (2003) (43)
Connecting the Dots: Potential of Data Integration to Identify Regulatory SNPs in Late-Onset Alzheimer's Disease GWAS Findings (2014) (43)
PTGER4 Expression-Modulating Polymorphisms in the 5p13.1 Region Predispose to Crohn's Disease and Affect NF-κB and XBP1 Binding Sites (2012) (42)
Functional significance of lipoprotein lipase HindIII polymorphism associated with the risk of coronary artery disease. (2008) (41)
Genetic studies of human apolipoproteins. XVIII. Apolipoprotein polymorphisms in Australian Aborigines. (1991) (41)
Role of common genetic polymorphisms in the LDL receptor gene in affecting plasma cholesterol levels in the general population. (1994) (41)
Genetic association studies of interleukin‐1 (IL‐1A and IL‐1B) and interleukin‐1 receptor antagonist genes and the risk of Alzheimer's disease (2000) (40)
No association of SORL1 SNPs with Alzheimer's disease (2008) (39)
Genetic variation in the apolipoprotein D gene among African blacks and its significance in lipid metabolism. (2002) (39)
Rarity of the Alzheimer disease-protective APP A673T variant in the United States. (2015) (39)
A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease (1999) (38)
Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease (2006) (38)
Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's disease (2005) (37)
Population distributions of APOE, APOH, and APOA4 polymorphisms and their relationships with quantitative plasma lipid levels among the Evenki herders of Siberia. (1996) (36)
Amino Acid Position 11 of HLA-DRβ1 is a Major Determinant of Chromosome 6p Association with Ulcerative Colitis (2011) (36)
A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I. (2003) (36)
Effects of the hepatic lipase gene and physical activity on coronary heart disease risk. (2003) (36)
The Khatri Sikh Diabetes Study (SDS): Study Design, Methodology, Sample Collection, and Initial Results (2006) (36)
Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing (2018) (36)
Distribution of transferrin (Tf) subtypes in Asian, Pacific and Australian Aboriginal populations: evidence for the existence of a new subtype TfC6. (1983) (36)
Chronic traumatic encephalopathy in a National Football League player. (2005) (35)
Vitamin D as a Principal Factor in Mediating Rheumatoid Arthritis-Derived Immune Response (2019) (35)
Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus (2011) (35)
TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease (2011) (35)
Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging (2018) (35)
Association of anti-oxidized LDL and candidate genes with severity of coronary stenosis in the Women's Ischemia Syndrome Evaluation study (2011) (35)
Genetic studies of human apolipoproteins: XII. Population genetics of apolipoproteins in Papua New Guinea (1990) (35)
Apolipoprotein A-IV polymorphism, and its role in determining variation in lipoprotein-lipid, glucose and insulin levels in normal and non-insulin-dependent diabetic individuals. (1991) (34)
Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. (2015) (34)
Genetic characterization of American and Western Samoans. (1994) (34)
Genetic studies of low-abundance human plasma proteins. V. Evidence for a second orosomucoid structural locus (ORM2) expressed in plasma. (1987) (34)
Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk (2016) (33)
Cognitive aging in persons with minimal amyloid-β and white matter hyperintensities (2013) (33)
Association of apolipoprotein(a) phenotypes in children with family history of premature coronary artery disease. (1994) (32)
Genetic effect of apolipoprotein(a) and apolipoprotein E polymorphisms on plasma quantitative risk factors for coronary heart disease in American black women. (1995) (32)
Evidence for the association of the S100β gene with low cognitive performance and dementia in the elderly (2007) (31)
Association of 32 type 1 diabetes risk loci in Pakistani patients. (2015) (31)
Association of Lipoprotein Lipase Gene Variation with the Physiological Components of the Insulin-Resistance Syndrome in the Population of the San Luis Valley, Colorado (1993) (31)
Complete DNA Sequence Variation in the Apolipoprotein H (β2‐glycoprotein I) Gene and Identification of Informative SNPs (2006) (30)
Amyloid &bgr; Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia (2018) (30)
Amyloid deposition and brain structure as long-term predictors of MCI, dementia, and mortality (2018) (30)
Plasma apolipoprotein A-I, apolipoprotein B, and lipoprotein(a) concentrations in normoglycemic Hispanics and non-Hispanic whites from the San Luis Valley, Colorado. (1997) (29)
Investigation of an amyloid precursor protein protective mutation (A673T) in a North American case-control sample of late-onset Alzheimer's disease (2014) (29)
Genetic Variation in the Paraoxonase‐3 (PON3) Gene is Associated with Serum PON1 Activity (2007) (29)
Racial differences in the distribution of a low density lipoprotein receptor-related protein (LRP) polymorphism and its association with serum lipoprotein, lipid and apolipoprotein levels. (1998) (29)
Gene–gene and gene–environment interactions in ulcerative colitis (2014) (29)
Genetic Variation in C-Reactive Protein (CRP) Gene May Be Associated with Risk of Systemic Lupus Erythematosus and CRP Concentrations (2008) (29)
Genetic studies of low abundance human plasma proteins. II. Population genetics of coagulation factor XIIIB. (1986) (29)
A Multiethnic Replication Study of Plasma Lipoprotein Levels-Associated SNPs Identified in Recent GWAS (2013) (28)
DNA sequence variation in human apolipoprotein C4 gene and its effect on plasma lipid profile. (2000) (28)
Population genetics of alpha-1-antitrypsin polymorphism in US whites, US blacks and African blacks. (1991) (27)
ApoA-IV Polymorphism Associated With Myocardial Infarction in Obese NIDDM Patients: The San Luis Valley Diabetes Study (1994) (27)
Estimation of the frequency of isoform–genotype discrepancies at the apolipoprotein E locus in heterozygotes for the isoforms (1992) (27)
Chronic traumatic encephalopathy in a national football league player. Part II. Commentary (2005) (27)
Associations between dietary factors and serum lipids by apolipoprotein E polymorphism. (1996) (27)
Genetic studies of human apolipoproteins. XV. An overview of IEF immunoblotting methods to screen apolipoprotein polymorphisms. (1990) (26)
Genome-Wide Association Study of Antiphospholipid Antibodies (2013) (26)
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
Identification of a New Susceptibility Locus for Systemic Lupus Erythematosus on Chromosome 12 in Individuals of European Ancestry (2016) (26)
Genetic variation in imprinted genes is associated with risk of late-onset Alzheimer's disease. (2015) (26)
Lack of association between α2-macroglobulin polymorphisms and Alzheimer's disease (2001) (26)
Structure of the human β2‐glycoprotein I (apolipoprotein H) gene* (1999) (26)
Genetic studies of human apolipoproteins. XVII: Population genetics of apolipoprotein polymorphisms in American Samoa. (1991) (25)
Single Nucleotide Polymorphisms in the Coding Region of the Apolipoprotein H (β2‐Glycoprotein I) Gene and their Correlation with the Protein Polymorphism, Anti‐β2Glycoprotein I Antibodies and Cardiolipin Binding: Description of Novel Haplotypes and Their Evolution (2004) (25)
Replication study of genome‐wide associated SNPs with late‐onset Alzheimer's disease (2011) (25)
Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease. (2012) (24)
Investigating gains in neurocognition in an Intervention Trial of Exercise (IGNITE): Protocol. (2019) (24)
Genetic association of two chromosome 14 genes (presenilin 1 and α1‐Antichymotrypsin) with Alzheimer's disease (1998) (23)
The apolipoprotein E epsilon 4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease. (1997) (23)
Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial. (2001) (23)
Structure-function analysis of D9N and N291S mutations in human lipoprotein lipase using molecular modelling. (2001) (23)
Meta-analysis of the Association Between Variants in SORL 1 and Alzheimer Disease (2011) (23)
Quantitative effects of the apolipoprotein E polymorphism in a biracial sample of 9-10-year-old girls. (1996) (23)
Apolipoprotein A-IV genetic polymorphism and its impact on quantitative traits in normoglycemic and non-insulin-dependent diabetic Hispanics from the San Luis Valley, Colorado. (1992) (22)
Genetic polymorphism of thyroxin-binding globulin (TBG) in the Pacific area. (1984) (22)
Phenotypic effects of apolipoprotein structural variation on lipid profiles. I. APO H and quantitative lipid measures in the healthy women study (1989) (22)
Genome-wide copy-number variation study of psychosis in Alzheimer's disease (2015) (21)
Lipoprotein lipase gene sequencing and plasma lipid profile[S] (2014) (21)
Comprehensive Evaluation of the Association of APOE Genetic Variation with Plasma Lipoprotein Traits in U.S. Whites and African Blacks (2014) (21)
Genetics of apolipoprotein H (β2-glycoprotein I) and anionic phospholipid binding (1998) (21)
Apolipoprotein E and Alpha-1-Antichymotrypsin Genotypes Do Not Predict Time to Psychosis in Alzheimer's Disease (2002) (20)
Phenotypic effects of apolipoprotein structural variation on lipid profiles. IV. Apolipoprotein polymorphisms in a small group of black women from the Healthy Women Study (1989) (20)
Genetic studies of human apolipoproteins. III. Polymorphism of apolipoprotein C-II. (1988) (20)
Genome-Wide Linkage Scan to Identify Loci Associated with Type 2 Diabetes and Blood Lipid Phenotypes in the Sikh Diabetes Study (2011) (20)
Distribution of plasma α1-antichymotrypsin levels in Alzheimer disease patients and controls and their genetic controls (2002) (20)
A Brief Synopsis on the Genetics of Alzheimer’s Disease (2018) (19)
Relationship of two apolipoprotein B polymorphisms with serum lipoprotein and lipid levels in African blacks. (1997) (19)
Molecular basis of the apolipoprotein H (beta 2-glycoprotein I) protein polymorphism. (1997) (19)
A simplified method for screening the apolipoprotein E polymorphism. (1991) (19)
Influence of two apo A4 polymorphisms at codons 347 and 360 on non-fasting plasma lipoprotein-lipids and apolipoproteins in Asian Indians. (1997) (19)
The impact of the apolipoprotein E polymorphism on the lipoprotein profile in insulin-dependent diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study IX. (1992) (19)
Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease. (2002) (19)
Structure of the human beta2-glycoprotein I (apolipoprotein H) gene. (1999) (19)
Impact of Genetic Variants in Human Scavenger Receptor Class B Type I (SCARB1) on Plasma Lipid Traits (2014) (18)
Racial and genetic determinants of plasma factor XIII activity (2000) (18)
Erratum: APOE*4–associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism (1995) (18)
Lack of association of 5 SNPs in the vicinity of the insulin-degrading enzyme (IDE) gene with late-onset Alzheimer's disease (2006) (17)
Genetic studies of human apolipoproteins. XI. The effect of the apolipoprotein C-II polymorphism on lipoprotein levels in Nigerian blacks. (1989) (17)
Prevalence of type 2 diabetes–associated complications in Pakistan (2016) (17)
Genetic studies of human apolipoproteins. IX. Apolipoprotein D polymorphism and its relation to serum lipoprotein lipid levels. (1989) (17)
Genome-Wide Association Identifies the First Risk Loci for Psychosis in Alzheimer Disease (2020) (17)
No association of DAPK1 and ABCA2 SNPs on chromosome 9 with Alzheimer's disease (2009) (17)
The application of network label propagation to rank biomarkers in genome-wide Alzheimer’s data (2014) (17)
A Rare Duplication on Chromosome 16p11.2 Is Identified in Patients with Psychosis in Alzheimer's Disease (2014) (17)
Association of tagSNPs in the urokinase‐plasminogen activator (PLAU) gene with Alzheimer's disease and associated quantitative traits (2007) (17)
Specificity of the STAT 4 Genetic Association for Severe Disease Manifestations of Systemic Lupus Erythematosus (2008) (17)
Genetic studies of low abundance human plasma proteins. III. Polymorphism of the C1R subcomponent of the first complement component. (1986) (16)
Gender‐specific nonrandom association between the α1‐antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease (1997) (16)
Highly polymorphic apolipoprotein A-IV locus in the baboon. (1990) (16)
Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer's disease is dependent on the psychosis phenotype (2012) (16)
Chimpanzee apolipoprotein H (β2-glycoprotein I): report on the gene structure, a common polymorphism, and a high prevalence of antiphospholipid antibodies (2001) (16)
Correlates of lipoprotein(a) levels in a biracial cohort of young girls: the NHLBI Growth and Health Study. (1999) (15)
A common deletion polymorphism in the apolipoprotein A4 gene and its significance in lipid metabolism. (1994) (15)
Hypervariable polymorphism of APO(a) in blacks and whites as reflected by phenotyping. (1994) (15)
Identifying genetic interactions associated with late-onset Alzheimer’s disease (2014) (15)
Apolipoprotein E Polymorphism in Alzheimer’s Disease: A Comparative Study of Two Research Populations from Spain and the United States (1998) (15)
Association studies of 22 candidate SNPs with late‐onset Alzheimer's disease (2009) (15)
Functional Polymorphisms of the Coagulation Factor II Gene (F2) and Susceptibility to Systemic Lupus Erythematosus (2011) (14)
Apolipoprotein J polymorphisms and serum HDL cholesterol levels in African blacks. (1999) (14)
Genomics and Functional Genomics of Alzheimer’s Disease (2021) (14)
Genetic studies of low-abundance human plasma proteins (1988) (14)
Population-based genome-wide association study of cognitive decline in older adults free of dementia: identification of a novel locus for the attention domain (2019) (14)
Polygenic Determinants of Alzheimer's Disease: Modulation of the Risk by α‐1‐Antichymotrypsin a (1996) (14)
Genetic studies of human apolipoproteins. XX. Genetic polymorphism of apolipoprotein J and its impact on quantitative lipid traits in normolipidemic subjects. (1991) (14)
Genetic contribution of SCARB1 variants to lipid traits in African Blacks: a candidate gene association study (2015) (14)
Heterogeneity of the apolipoprotein H*3 allele and its role in affecting the binding of apolipoprotein H (β2-glycoprotein I) to anionic phospholipids (2004) (13)
Genetic link of type 1 diabetes susceptibility loci with rheumatoid arthritis in Pakistani patients (2015) (13)
Genetic studies of low-abundance human plasma proteins. VI. Polymorphism of hemopexin. (1987) (13)
Apolipoprotein A kringle 4 polymorphism and serum lipoprotein (a) concentrations in African blacks. (1998) (13)
Proficiency of data interpretation: identification of signaling SNPs/specific loci for coronary artery disease (2017) (13)
Heterogeneity of factor XIIIB: A new method for the determination of factor XIIIB phenotypes by isoelectric focusing in 6 M urea (1985) (12)
Whole-Exome Sequencing Analysis of Alzheimer's Disease in Non-APOE*4 Carriers. (2020) (12)
Resequencing of the CETP gene in American whites and African blacks: Association of rare and common variants with HDL-cholesterol levels. (2016) (12)
Association of APOE polymorphisms and stressful life events with dementia in a Pakistani population (2014) (12)
Relationships between Cerebrovascular Events, APOE Polymorphism and Alzheimer’s Disease in a Community Sample (2000) (11)
Apolipoprotein H (beta-2-glycoprotein I) polymorphism in Asians. (1992) (11)
Genetic variants associated with susceptibility to psychosis in late-onset Alzheimer’s disease families (2015) (11)
A Few Corrections to Our Article (2002) (11)
The impact of factor XIIIa V34L polymorphism on plasma factor XIII activity in the Chinese and Asian Indians from Singapore (2003) (11)
Apolipoprotein H polymorphism and serum lipoprotein and apolipoprotein levels in two Asian populations. (1993) (11)
Isoelectric focusing of superoxide dismutase: report of the unique SOD A*2 allele in a US white population. (1988) (11)
Apolipoprotein E-C1-C4-C2 gene cluster region and inter-individual variation in plasma lipoprotein levels: a comprehensive genetic association study in two ethnic groups (2019) (11)
Genetic studies of low‐abundance human plasma proteins: X. Coagulation factor XIIIB variants in blacks (1989) (11)
Alpha2-HS glycoprotein phenotypes and quantitative hormone and bone measures in postmenopausal women (1990) (10)
Hippocampal sclerosis, TDP‐43, and the duration of the symptoms of dementia of AD patients (2020) (10)
A sensitive immunoblotting technique to identify thyroxin-binding globulin protein heterogeneity after isoelectric focusing (1986) (10)
Genetic Determinants of Survival in Patientswith Alzheimer’s Disease. (2015) (10)
APOE Gene Polymorphism and Risk of Coronary Stenosis in Pakistani Population (2015) (10)
Cladistic Analysis of Human Apolipoprotein A4 Polymorphisms in Relation to Quantitative Plasma Lipid Risk Factors of Coronary Heart Disease (2003) (10)
Genetic studies of human apolipoproteins. II. A rapid one‐dimensional isoelectric focusing technique to characterize apolipoproteins A‐I, A‐II, A‐IV and C‐II of unfractionated plasma (1987) (10)
Apolipoprotein A polymorphisms and plasma lipoprotein(a) concentrations in non-Hispanic Whites and Hispanics. (2000) (10)
Functional analysis of plasma α2-macroglobulin from Alzheimer's disease patients with the A2M intronic deletion (2003) (10)
Association of a Common G6PC2 Variant with Fasting Plasma Glucose Levels in Non-Diabetic Individuals (2009) (10)
Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease (2018) (9)
Genetic studies of PGM1 subtypes: population data from the Asian-Pacific area. (1984) (9)
Genetic Polymorphisms of Apolipoproteins A-IV, E and H in Koreans (1998) (9)
Recombinant hepatitis B surface antigen and anionic phospholipids share a binding region in the fifth domain of beta2-glycoprotein I (apolipoprotein H). (2008) (9)
Resequencing of LPL in African Blacks and associations with lipoprotein–lipid levels (2015) (9)
Dementia among elderly apolipoprotein E type 4/4 homozygotes: A prospective study (1995) (9)
Re: Genetic effect of α1-antichymotrypsin on the risk of Alzheimer disease (1997) (9)
Predicting resistance to amyloid-beta deposition and cognitive resilience in the oldest-old (2020) (8)
Genetic polymorphism in the cathepsin G gene and the risk of Alzheimer's disease (2001) (8)
Short Report on DNA Marker at Candidate Locus (1996) (8)
Small nucleolar RNAs in plasma extracellular vesicles and their discriminatory power as diagnostic biomarkers of Alzheimer’s disease (2021) (8)
Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma. (2021) (8)
Replication of European Rheumatoid Arthritis Loci in a Pakistani Population (2013) (8)
Genetic studies of low-abundance human plasma proteins. XIII. Population genetics of C1R complement subcomponent and description of new variants. (1989) (8)
The APO E4 allele and cognition in New Mexico Hispanic elderly. (2002) (8)
Investigating the GWAS-Implicated Loci for Rheumatoid Arthritis in the Pakistani Population (2020) (8)
Hemopexin: a unique genetic polymorphism in populations of African ancestry. (1993) (8)
No association of dynamin binding protein (DNMBP) gene SNPs and Alzheimer's disease (2008) (7)
Lack of association between alpha2-macroglobulin polymorphisms and Alzheimer's disease. (2001) (7)
Population-Based Resequencing of LIPG and ZNF202 Genes in Subjects with Extreme HDL Levels (2012) (7)
GENETIC STUDIES OF LOW‐ABUNDANCE HUMAN PLASMA PROTEINS: VII. HETEROGENEITY OF THE C1, SUBCOMPONENT OF THE FIRST COMPLEMENT COMPONENT (1987) (7)
Apolipoprotein H Promoter Polymorphisms in Relation to Lupus and Lupus-related Phenotypes (2009) (7)
A replication study of 49 Type 2 diabetes risk variants in a Punjabi Pakistani population (2016) (7)
Genetic studies of human apolipoproteins. XIII. Quantitative polymorphism of apolipoprotein C-III in the Mayans of the Yucatán Peninsula. (1990) (7)
Genetic studies of low-abundance human plasma proteins. I. Microheterogeneity of zinc-α2-glycoprotein in biological fluids (1986) (7)
Apolipoprotein (a): A comparison of isoforms identified by sodium dodecyl sulfate‐polyacrylamide gel electrophoresis or by sodium dodecyl sulfate‐agarose gel electrophoresis (1993) (7)
A sequencing study of CTLA4 in Pakistani rheumatoid arthritis cases (2020) (7)
A highly sensitive and nonradioactive mutation detection method based on vertical gradient temperature single‐strand conformation polymorphism (2001) (6)
Plasma lipoprotein(a) distribution and its correlates among Samoans. (2000) (6)
Two new alleles in the tetranucleotide repeat polymorphism at the lipoprotein lipase (LPL) locus (1992) (6)
Functional and genetic characterization of the promoter region of apolipoprotein H (β2‐glycoprotein I) (2010) (6)
Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin. (1996) (6)
Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease (2019) (6)
The catechol-o-methyltransferase Val158 Met polymorphism modulates organization of regional cerebral blood flow response to working memory in adults. (2013) (6)
Apolipoprotein polymorphisms and phenotypic variability in American Samoans: Preliminary data (1993) (6)
Re-evaluation of the proposed interrelationship between thyroxine-binding globulin (TBG) and alpha1-antitrypsin (PI). (1984) (6)
Association between ACT polymorphism and Alzheimer's disease (1998) (6)
Population genetics of the vitamin D binding protein (GC) subtypes in the Asian-Pacific area: Description of new alleles at the GC locus (2004) (6)
Genetic studies of low abundance human plasma proteins. VIII. Inherited structural variation in antithrombin III. (1988) (5)
Alzheimer’s disease pathology in a community-based sample of older adults without dementia: The MYHAT neuroimaging study (2020) (5)
Lack of association of two chromosome 10q24 SNPs with Alzheimer's disease (2006) (5)
Genetic studies of human apolipoproteins: XIV. A simple agarose isoelectric focusing gel method for apolipoprotein E phenotyping (1990) (5)
Apolipoprotein E genotype and CBF in traumatic brain injured patients. (2006) (5)
Genetic studies of low-abundance human plasma proteins. IV. Improved typing of alpha-1 acid glycoprotein (orosomucoid) by isoelectric focusing and immunoblotting. (1987) (5)
Population genetic studies using isoelectric focussing in the Asian, Pacific and Australian area (1984) (5)
Genetic data and cognitively-defined late-onset Alzheimer’s disease subgroups (2018) (4)
Identification and characterization of a novel 5 bp deletion in a putative insulin response element in the lipoprotein lipase gene. (2009) (4)
Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90 (2022) (4)
Association of VPREB1 Gene Copy Number Variation and Rheumatoid Arthritis Susceptibility (2020) (4)
Amyloid deposition is associated with different patterns of hippocampal connectivity in men versus women (2019) (4)
Cardiac-induced cerebral pulsatility, brain structure, and cognition in middle and older-aged adults (2021) (4)
Assessment of genetic risk of type 2 diabetes among Pakistanis based on GWAS-implicated loci. (2021) (4)
Genetic studies of low abundance human plasma proteins VIII. Inherited structural variation in antithrombin III (1988) (3)
Association Study of Coronary Artery Disease-Associated Genome-Wide Significant SNPs with Coronary Stenosis in Pakistani Population (2020) (3)
Population genetics of apolipoproteins A-IV, E, and H, and the angiotensin converting enzyme (ACE): associations with lipids, and apolipoprotein levels in American Samoans. (2004) (3)
Genetic Effect of Two APOA Repeat Polymorphisms (Kringle 4 and Pentanucleotide Repeats) on Plasma Lp(a) Levels in American Samoans (2001) (3)
Alpha-1-antitrypsin (PI) and vitamin-D binding globulin (GC) phenotypes in rheumatoid arthritis: absence of an association. (1989) (3)
Erratum to: Genetic link of type 1 diabetes susceptibility loci with rheumatoid arthritis in Pakistani patients (2015) (3)
Association of three lipoprotein lipase polymorphisms with coronary artery disease in Chinese and Asian Indians. (2010) (3)
Genetic polymorphism in the persyn (γ-synuclein) gene and the risk of Alzheimer's disease (1999) (3)
Genetic studies of low-abundance human plasma proteins. XI. Linkage analysis and population genetics of the C1S subcomponent of the first complement component. (1989) (3)
A Likelihood-Based Approach for Missing Genotype Data (2010) (3)
Hepatic lipase (LIPC) sequencing in individuals with extremely high and low high-density lipoprotein cholesterol levels (2020) (2)
Targeted Lipidomics To Measure Phospholipids and Sphingomyelins in Plasma: A Pilot Study To Understand the Impact of Race/Ethnicity in Alzheimer's Disease. (2022) (2)
Investigation of an APP protective mutation (A673T) in a North American case-control sample of late-onset Alzheimer’s disease (2014) (2)
Genetic variation in the apolipoproteins C-II and C-III. (1988) (2)
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study (2023) (2)
Genetic studies of low-abundance human plasma proteins. IX. A new allele at the complement subcomponent C1R structural locus. (1988) (2)
Genetic polymorphism of apolipoprotein A-IV in the chimpanzee: common deletion of a conserved 12-nucleotide tandem repeat. (1994) (2)
Genetic polymorphism in the persyn (gamma-synuclein) gene and the risk of Alzheimer's disease. (1999) (2)
Correction: Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups (2019) (2)
Gene Expression and Cardiometabolic Phenotypes of Vitamin D-Deficient Overweight and Obese Black Children (2019) (1)
Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer's disease is dependent on the psychosis phenotype (2012) (1)
The application of network label propagation to rank biomarkers in genome-wide Alzheimer’s data (2014) (1)
Reply to Reed (1992) (1)
Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real-world population-based cohort. (2023) (1)
In Pre-Clinical AD Small Vessel Disease is Associated With Altered Hippocampal Connectivity and Atrophy. (2022) (1)
Interaction of apolipoprotein E genotype and dietary cholesterol in determining plasma cholesterol levels. (1992) (1)
DOPAMINE-4 RECEPTOR AND COGNITION IN ALZHEIMER's DISEASE (1999) (1)
Alpha-1-antitrypsin (PI) and transferrin (Tf) subtyping in asian, pacific and australian aboriginal populations (1983) (1)
Re: Genetic effect of alpha 1-antichymotrypsin on the risk of Alzheimer disease. (1997) (1)
Genome‐wide meta‐analysis of age‐related cognitive decline in population‐based older individuals (2021) (1)
Three F XIIIA gene loci? (1989) (1)
Novel CYP1B1-RMDN2 Alzheimers disease locus identified by genome-wide association analysis of cerebral tau deposition on PET (2023) (1)
PCR3: PCR in situ hybridization (1999) (1)
Identification of novel Alzheimer genes using population-based association studies (2000) (0)
Genetic link of type 1 diabetes susceptibility loci with rheumatoid arthritis in Pakistani patients (2015) (0)
Association analysis of 23 susceptibility loci with risk of dementia in a Pakistani population (2015) (0)
Geographic and age related variations in the gene frequencies of abo and rh blood groups in the population of punjab pakistan 2 (1979) (0)
Genetic insights of all‐cause and vascular dementia through genome‐wide association studies (2022) (0)
Subject Index Vol. 19, 2000 (2000) (0)
Longitudinal changes in fibrillar amyloid-beta deposition across the cognitive spectrum: Effect of the APOE4 allele (2011) (0)
Analysis of the reported relationship between thyroxin-binding globulin and alpha-1-antitrypsin heterogeneity (1987) (0)
Impact of Common Type 2 Diabetes Risk Polymorphisms in Asian Indian Sikhs : Gene-Gene Interaction May Improve Risk Prediction (2007) (0)
A whole‐genome‐sequencing study to identify genetic variants associated with Alzheimer’s disease progression (2022) (0)
Genome-Wide Association Study of Incident Dementia in a Community-Based Sample of Older Subjects (2022) (0)
Small nucleolar RNAs in plasma and their discriminatory power as diagnostic biomarkers of Alzheimer's disease (2021) (0)
Genetic studies of human apolipoproteins. XIX. Apolipoproteins E and A-IV phenotyping from whole blood and blood stains. (1991) (0)
Referees for volume 29 (1991) (0)
Lupus Nephritis Susceptibility Markers in PDGRFA-GSX2, SLC5A11, ID4, and HAS2-SNTB1 Regions Identified From a Meta-Analysis of Genome Wide Association Studies of Women with Systemic Lupus Erythematosus (2011) (0)
TARGETED SEQUENCING OF GWAS-IMPLICATED LOCI IN ALZHEIMER’S DISEASE (2017) (0)
Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease (2023) (0)
P4-131 Association of the APOE promoter polymorphisms with late-onset Alzheimer's disease (2004) (0)
Apolipoprotein D distribution in normal and Alzheimer's brains: Implications for its role in the pathogenesis of Alzheimer's disease (2000) (0)
Phenotypic effects of the apolipoprotein e locus in white and black perimenopausal healthy women (1989) (0)
PREDICTING RESILIENCY AGAINST AMYLOID-BETA DEPOSITION, COGNITIVE IMPAIRMENT, AND THEIR COMBINATION IN THE OLDEST-OLD (2018) (0)
PRELIMINARY RESULTS ON THE IMPACT OF APOE GENOTYPES ON CEREBROSPINAL FLUID (CSF) EXCITATORY AMINO ACIDS (EAA) AND METABOLITES IN TRAUMATIC BRAIN INJURED (TBI) ADULTS (1999) (0)
Identifying Genetic Interactions Associated with La te-Onset 1 (2013) (0)
IC-P-019 LONGITUDINAL ACCUMULATION OF b AMYLOID ON PET IN DEMENTIAWITH LEWY BODIES AND RELATIONSHIP TO CLINICAL DISEASE PROGRESSION PREDICTING RESILIENCYAGAINST AMYLOID-BETA DEPOSITION, COGNITIVE IMPAIRMENT, AND THEIR COMBINATION IN THE OLDEST-OLD (2018) (0)
Investigation of PGM 13 , PGM 16 , and PGM 17 Variants by Isoelectric Focussing . Evidence for New Subtypes of the PGM and PGM Alleles (0)
GENOME-WIDE ASSOCIATION STUDIES IN GENOMIC MEDICINE - ARE WE THERE YET? (2008) (0)
Association of Fc Gamma Receptor 3B Gene Copy Number Variation with Rheumatoid Arthritis Susceptibility (2022) (0)
Rare/uncommon (MAF<5%) variants analysis with lipid traits in African Blacks. (2014) (0)
AB069. Proficiency of data interpretation: identification of signaling single nucleotides polymorphism for coronary artery disease (2017) (0)
Role of the apolipoprotein A-IV polymorphism at codon 347 in affecting normal plasma lipid and apolipoprotein variation (1994) (0)
Investigation of the independent role of a rare APOE variant (L28P; APOE*4Pittsburgh) in late-onset Alzheimer disease (2022) (0)
A comprehensive association study of apolipoprotein E-C1-C4-C2 gene cluster variation with plasma lipoprotein traits. (2017) (0)
AB070. Association of genome-wide significant single-nucleotide polymorphisms with coronary artery disease in Pakistani population: a case-control study (2017) (0)
P4-120 The calcium sensing receptor in Alzheimer disease susceptibility (2004) (0)
PREDICTING RESILIENCY AGAINST AMYLOID-BETA DEPOSITION, COGNITIVE IMPAIRMENT, AND THEIR COMBINATION IN THE OLDEST-OLD (2018) (0)
AMYLOID DEPOSITION AND BRAIN STRUCTURE AS LONG-TERM PREDICTORS OF DEMENTIA IN COGNITIVELY NORMAL AND MCI INDIVIDUALS (2017) (0)
A meta-analysis of genome-wide association studies identifies new genetic loci associated with all-cause and vascular dementia (2021) (0)
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease (2018) (0)
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) (0)
Referees for Volume 35 (2004) (0)
Meta‐analysis of age‐related cognitive decline reveals a novel locus for the attention domain and implicates a COVID‐19 related gene for global cognitive function (2022) (0)
Investigation of PGM13, PGM16, and PGM17 variants by isoelectric focussing. Evidence for new subtypes of the PGM13 and PGM17 alleles (2004) (0)
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
Brief communication Association of CLU and PICALM variants with Alzheimer's disease (2012) (0)
Genome‐wide association study of plasma apolipoprotein E levels and risk of dementia in older adults (2022) (0)
DOPAMINE RECEPTOR GENETIC VARIATION AND MOTIVATIONAL DISTURBANCE IN ALZHEIMER's DISEASE (1999) (0)
Brief Communication: Hemopexin A Unique Genetic Polymorphism in Populations of African Ancestery (1993) (0)
Predictors of Dementia in the Oldest Old (2020) (0)
Genome‐wide interaction study of smoking in Alzheimer’s disease (2020) (0)
P4-139 Lack of association between polymorphisms in the brain-derived neurotrophic factor (BDNF) and sporadic late-onset Alzheimer's disease in caucasians (2004) (0)
ASSOCIATION OF ALZHEIMER’S DISEASE GENETIC RISK VARIANTS WITH PATHOLOGY ENDOPHENOTYPES (2018) (0)
Referees for volume 29 (2004) (0)
Correspondence between blood‐based amyloid‐β by immuno‐precipitation mass spectrometry and PIB‐PET imaging in a population cohort (2020) (0)
Gene–gene and gene–environment interactions in ulcerative colitis (2013) (0)
Identifying genetic interactions associated with late-onset Alzheimer’s disease (2014) (0)
Population genetic studies of PI, Tf, Gc and PGM1 subtypes among various caste groups in North India. (1984) (0)
Acknowledgement to the Reviews (1998) (0)
Exploration of shared genetic susceptibility loci between type 1 diabetes and rheumatoid arthritis in the Pakistani population (2019) (0)
Genetic Analysis at the Phenotypic Level (1998) (0)
P4-078 Alpha-1 antichymotrypsin (ACT or serpina3) may affect age-at-onset of Alzheimer's disease (2004) (0)
Isoelectric focussing studies of PGM1, and Gc polymorphisms in different ethnic groups from the asian, pacific and australian area (1984) (0)
An improved method for complement subcomponent C1R typing. (1990) (0)
Allele frequencies of the SNPs within the 5p13.1 in German replication cohort with Crohn's disease patients and controls. (2012) (0)
Contents Vol. 19, 2000 (2000) (0)
Investigation of PGM1(3), PGM1(6), and PGM1(7) variants by isoelectric focusing. Evidence for new subtypes of the PGM1(3) and PGM1(7) alleles. (1983) (0)
Erratum to: Genetic link of type 1 diabetes susceptibility loci with rheumatoid arthritis in Pakistani patients (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With M. Ilyas Kamboh?

M. Ilyas Kamboh is affiliated with the following schools:

M. Ilyas Kamboh's Academic­Influence.com Rankings

Why Is M. Ilyas Kamboh Influential?

M. Ilyas Kamboh's Published Works

Published Works

What Schools Are Affiliated With M. Ilyas Kamboh?

M. Ilyas Kamboh's AcademicInfluence.com Rankings